Use of progesterone to prevent preterm birth at a tertiary care center

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 52, Issue 4, 2007, Pages 280-284

  Bailit, Jennifer L ^a   Berkowitz, Richard ^b   Thorp, John M ^b   Cleary, Kirsten ^b   Hartmann, Katherine E ^b   Mercer, Brian M ^b  

^a METROHEALTH MEDICAL CENTER   (United States)

^b NONE

Author keywords

Pregnancy complications; Preterm birth; Progesterone

Indexed keywords

HYDROXYPROGESTERONE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL CARE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ADULT; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; OBSTETRIC LABOR, PREMATURE; OBSTETRICS; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PROGESTERONE; PROGESTINS; RISK FACTORS;

EID: 34247646558     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Copper R, Goldenberg R, Creasy R, et al: A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol 1993;168:78-84
2. Piecuch RE, Leonard CH, Cooper BA, et al: Outcome of infants born at 24-26 weeks' gestation: II. Neurodevelopmental outcome. Obstet Gynecol 1997;90:809-814
3. Kilpatrick SJ, Schlueter MA, Piecuch R, et al: Outcome of infants born at 24-26 weeks' gestation: I. Survival and cost. Obstet Gynecol 1997;90:803-808
4. Meis PJ, Klebanoff M, Thom E, et al: Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-2385
5. da Fonseca EB, Bittar RE, Carvalho MH, et al: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419-424
6. Dodd JM, Crowther CA, Cincotta R, et al: Progesterone supplementation for preventing preterm birth: A systematic review and meta-analysis. Acta Obstet Gynecol Scand 2005;84: 526-533
7. Sanchez-Ramos L, Kaunitz AM, Delke I: Progestational agents to prevent preterm birth: A meta-analysis of randomized controlled trials. Obstet Gynecol 2005;105:273-279
8. U.S. Preventive Services Task Force: Guide to clinical preventive services: Report of the U.S. Preventive Health Services Task Force. Baltimore, Weilliams & Wilkins, 1996
9. Petrini JR, Callaghan WM, Klebanoff M, et al: Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States. Obstet Gynecol 2005;105:267-272
10. Liggins GC, Howie RN: A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-525
11. Wright LL, Verter J, Younes N, et al: Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: The NICHD Neonatal Research Network. Am J Obstet Gynecol 1995;173:269-274
12. Goldenberg R: The management of preterm labor. Obstet Gynecol 2002;100:1020-1037
13. Parer JT: Obstetric technologies: What determines clinical acceptance or rejection of results of randomized controlled trials? Am J Obstet Gynecol 2003;188:1622-1625
14. Haines A, Donald A: Looking forward: Getting research findings into practice: Making better use of research findings. BMJ 1998;317:72-75
15. Wedgewood Pharmacy, wedgewoodpharmacy.com
16. Rittenhouse DR, Braveman P, Marchi K: Improvements in prenatal insurance coverage and utilization of care in California: An unsung public health victory. Matern Child Health J 2003;7:75-86
17. Braveman P, Marchi K, Egerter S, et al: Barriers to timely prenatal care among women with insurance: The importance of prepregnancy factors. Obstet Gynecol 2000;95:874-880